1 All Trans Retinoic Acid Market Overview
1.1 Product Overview and Scope of All Trans Retinoic Acid
1.2 All Trans Retinoic Acid Segment by Type
1.2.1 Global All Trans Retinoic Acid Market Value Comparison by Type (2023-2029)
1.2.2 Rx
1.2.3 OTC
1.3 All Trans Retinoic Acid Segment by Application
1.3.1 Global All Trans Retinoic Acid Market Value by Application: (2023-2029)
1.3.2 Skin Disease
1.3.3 Leukemia
1.4 Global All Trans Retinoic Acid Market Size Estimates and Forecasts
1.4.1 Global All Trans Retinoic Acid Revenue 2018-2029
1.4.2 Global All Trans Retinoic Acid Sales 2018-2029
1.4.3 Global All Trans Retinoic Acid Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 All Trans Retinoic Acid Market Competition by Manufacturers
2.1 Global All Trans Retinoic Acid Sales Market Share by Manufacturers (2018-2023)
2.2 Global All Trans Retinoic Acid Revenue Market Share by Manufacturers (2018-2023)
2.3 Global All Trans Retinoic Acid Average Price by Manufacturers (2018-2023)
2.4 Global All Trans Retinoic Acid Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of All Trans Retinoic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of All Trans Retinoic Acid, Product Type & Application
2.7 All Trans Retinoic Acid Market Competitive Situation and Trends
2.7.1 All Trans Retinoic Acid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest All Trans Retinoic Acid Players Market Share by Revenue
2.7.3 Global All Trans Retinoic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 All Trans Retinoic Acid Retrospective Market Scenario by Region
3.1 Global All Trans Retinoic Acid Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global All Trans Retinoic Acid Global All Trans Retinoic Acid Sales by Region: 2018-2029
3.2.1 Global All Trans Retinoic Acid Sales by Region: 2018-2023
3.2.2 Global All Trans Retinoic Acid Sales by Region: 2024-2029
3.3 Global All Trans Retinoic Acid Global All Trans Retinoic Acid Revenue by Region: 2018-2029
3.3.1 Global All Trans Retinoic Acid Revenue by Region: 2018-2023
3.3.2 Global All Trans Retinoic Acid Revenue by Region: 2024-2029
3.4 North America All Trans Retinoic Acid Market Facts & Figures by Country
3.4.1 North America All Trans Retinoic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America All Trans Retinoic Acid Sales by Country (2018-2029)
3.4.3 North America All Trans Retinoic Acid Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe All Trans Retinoic Acid Market Facts & Figures by Country
3.5.1 Europe All Trans Retinoic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe All Trans Retinoic Acid Sales by Country (2018-2029)
3.5.3 Europe All Trans Retinoic Acid Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific All Trans Retinoic Acid Market Facts & Figures by Country
3.6.1 Asia Pacific All Trans Retinoic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific All Trans Retinoic Acid Sales by Country (2018-2029)
3.6.3 Asia Pacific All Trans Retinoic Acid Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America All Trans Retinoic Acid Market Facts & Figures by Country
3.7.1 Latin America All Trans Retinoic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America All Trans Retinoic Acid Sales by Country (2018-2029)
3.7.3 Latin America All Trans Retinoic Acid Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa All Trans Retinoic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa All Trans Retinoic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa All Trans Retinoic Acid Sales by Country (2018-2029)
3.8.3 Middle East and Africa All Trans Retinoic Acid Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global All Trans Retinoic Acid Sales by Type (2018-2029)
4.1.1 Global All Trans Retinoic Acid Sales by Type (2018-2023)
4.1.2 Global All Trans Retinoic Acid Sales by Type (2024-2029)
4.1.3 Global All Trans Retinoic Acid Sales Market Share by Type (2018-2029)
4.2 Global All Trans Retinoic Acid Revenue by Type (2018-2029)
4.2.1 Global All Trans Retinoic Acid Revenue by Type (2018-2023)
4.2.2 Global All Trans Retinoic Acid Revenue by Type (2024-2029)
4.2.3 Global All Trans Retinoic Acid Revenue Market Share by Type (2018-2029)
4.3 Global All Trans Retinoic Acid Price by Type (2018-2029)
5 Segment by Application
5.1 Global All Trans Retinoic Acid Sales by Application (2018-2029)
5.1.1 Global All Trans Retinoic Acid Sales by Application (2018-2023)
5.1.2 Global All Trans Retinoic Acid Sales by Application (2024-2029)
5.1.3 Global All Trans Retinoic Acid Sales Market Share by Application (2018-2029)
5.2 Global All Trans Retinoic Acid Revenue by Application (2018-2029)
5.2.1 Global All Trans Retinoic Acid Revenue by Application (2018-2023)
5.2.2 Global All Trans Retinoic Acid Revenue by Application (2024-2029)
5.2.3 Global All Trans Retinoic Acid Revenue Market Share by Application (2018-2029)
5.3 Global All Trans Retinoic Acid Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Chongqing Huabang
6.1.1 Chongqing Huabang Corporation Information
6.1.2 Chongqing Huabang Description and Business Overview
6.1.3 Chongqing Huabang All Trans Retinoic Acid Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Chongqing Huabang All Trans Retinoic Acid Product Portfolio
6.1.5 Chongqing Huabang Recent Developments/Updates
6.2 Cheplapharm Arzneimittel
6.2.1 Cheplapharm Arzneimittel Corporation Information
6.2.2 Cheplapharm Arzneimittel Description and Business Overview
6.2.3 Cheplapharm Arzneimittel All Trans Retinoic Acid Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cheplapharm Arzneimittel All Trans Retinoic Acid Product Portfolio
6.2.5 Cheplapharm Arzneimittel Recent Developments/Updates
6.3 OLON S.P.A
6.3.1 OLON S.P.A Corporation Information
6.3.2 OLON S.P.A Description and Business Overview
6.3.3 OLON S.P.A All Trans Retinoic Acid Sales, Revenue and Gross Margin (2018-2023)
6.3.4 OLON S.P.A All Trans Retinoic Acid Product Portfolio
6.3.5 OLON S.P.A Recent Developments/Updates
6.4 Siegfried Evionnaz
6.4.1 Siegfried Evionnaz Corporation Information
6.4.2 Siegfried Evionnaz Description and Business Overview
6.4.3 Siegfried Evionnaz All Trans Retinoic Acid Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siegfried Evionnaz All Trans Retinoic Acid Product Portfolio
6.4.5 Siegfried Evionnaz Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 All Trans Retinoic Acid Industry Chain Analysis
7.2 All Trans Retinoic Acid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 All Trans Retinoic Acid Production Mode & Process
7.4 All Trans Retinoic Acid Sales and Marketing
7.4.1 All Trans Retinoic Acid Sales Channels
7.4.2 All Trans Retinoic Acid Distributors
7.5 All Trans Retinoic Acid Customers
8 All Trans Retinoic Acid Market Dynamics
8.1 All Trans Retinoic Acid Industry Trends
8.2 All Trans Retinoic Acid Market Drivers
8.3 All Trans Retinoic Acid Market Challenges
8.4 All Trans Retinoic Acid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
オールトランスレチノイン酸のグローバル市場2023年：Rx、OTC |
| 【英語タイトル】Global All Trans Retinoic Acid Market Research Report 2023 | |
 | ・商品コード：QYR23MA8660 ・発行会社（調査会社）：QYResearch ・発行日：2023年3月 ・ページ数：66 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD2,900 ⇒換算￥377,000 | 見積依頼/購入/質問フォーム |
| Multi User（5名様閲覧用） | USD4,350 ⇒換算￥565,500 | 見積依頼/購入/質問フォーム |
| Enterprise License（同一法人内共有可） | USD5,800 ⇒換算￥754,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 本調査レポートは世界のオールトランスレチノイン酸市場について調査・分析し、世界のオールトランスレチノイン酸市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（Rx、OTC）、用途別セグメント分析（皮膚病、白血病）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Chongqing Huabang、Cheplapharm Arzneimittel、OLON S.P.A、Siegfried Evionnazなどが含まれています。世界のオールトランスレチノイン酸市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、オールトランスレチノイン酸市場規模を推定する際に考慮しました。 ・オールトランスレチノイン酸市場の概要 - 製品の定義 - オールトランスレチノイン酸のタイプ別セグメント - 世界のオールトランスレチノイン酸市場規模：タイプ別分析（Rx、OTC） - オールトランスレチノイン酸の用途別セグメント - 世界のオールトランスレチノイン酸市場規模：用途別分析（皮膚病、白血病） - 世界のオールトランスレチノイン酸市場規模予測（2018年-2029年） - オールトランスレチノイン酸の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - オールトランスレチノイン酸市場の競争状況およびトレンド ・オールトランスレチノイン酸の地域別市場規模 - 北米のオールトランスレチノイン酸市場規模（2018年-2029年） - アメリカのオールトランスレチノイン酸市場規模（2018年-2029年） - ヨーロッパのオールトランスレチノイン酸市場規模（2018年-2029年） - アジア太平洋のオールトランスレチノイン酸市場規模（2018年-2029年） - 中国のオールトランスレチノイン酸市場規模（2018年-2029年） - 日本のオールトランスレチノイン酸市場規模（2018年-2029年） - 韓国のオールトランスレチノイン酸市場規模（2018年-2029年） - インドのオールトランスレチノイン酸市場規模（2018年-2029年） - オーストラリアのオールトランスレチノイン酸市場規模（2018年-2029年） - 中南米のオールトランスレチノイン酸市場規模（2018年-2029年） - 中東・アフリカのオールトランスレチノイン酸市場規模（2018年-2029年） ・タイプ別セグメント：Rx、OTC - 世界のオールトランスレチノイン酸のタイプ別販売量（2018年-2023年） - 世界のオールトランスレチノイン酸のタイプ別売上（2018年-2023年） - 世界のオールトランスレチノイン酸のタイプ別価格 ・用途別セグメント：皮膚病、白血病 - 世界のオールトランスレチノイン酸の用途別販売量（2018年-2023年） - 世界のオールトランスレチノイン酸の用途別売上（2018年-2023年） - 世界のオールトランスレチノイン酸の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Chongqing Huabang、Cheplapharm Arzneimittel、OLON S.P.A、Siegfried Evionnaz ・産業チェーンと販売チャネルの分析 - オールトランスレチノイン酸産業チェーン分析 - オールトランスレチノイン酸の主要原材料 - オールトランスレチノイン酸の販売チャネル - オールトランスレチノイン酸のディストリビューター - オールトランスレチノイン酸の主要顧客 ・オールトランスレチノイン酸市場ダイナミクス - オールトランスレチノイン酸の業界動向 - オールトランスレチノイン酸市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
All-trans retinoic acid is a metabolic intermediate of vitamin A in the body, which mainly affects bone growth and promotes epithelial cell proliferation, differentiation, keratolysis and other metabolic effects. For the treatment of acne vulgaris, psoriasis, ichthyosis, lichen planus, pityriasis rubra pilaris, keratosis pilaris, squamous cell carcinoma and melanoma.
Highlights
The global All Trans Retinoic Acid market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for All Trans Retinoic Acid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for All Trans Retinoic Acid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of All Trans Retinoic Acid include Chongqing Huabang, Cheplapharm Arzneimittel, OLON S.P.A and Siegfried Evionnaz, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for All Trans Retinoic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding All Trans Retinoic Acid.
The All Trans Retinoic Acid market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global All Trans Retinoic Acid market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the All Trans Retinoic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chongqing Huabang
Cheplapharm Arzneimittel
OLON S.P.A
Siegfried Evionnaz
Segment by Type
Rx
OTC
Segment by Application
Skin Disease
Leukemia
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of All Trans Retinoic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of All Trans Retinoic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
| ★調査レポート[オールトランスレチノイン酸のグローバル市場2023年：Rx、OTC] (コード：QYR23MA8660)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[オールトランスレチノイン酸のグローバル市場2023年：Rx、OTC]についてメールでお問い合わせ |
